Gregg Lapointe

Current CEO and Co-Founder of Cerium Pharmaceuticals, Inc. and on the Board of Trustees of the Keck Graduate Institute of Applied Life Sciences. Current and Past Boards include: SciClone, Immunocellular, Pharmaceuticals Research and Manufacturers of America (PhRMA), Raptor, Soligenix, Rigel, Cytori and Questcor. He was COO and CEO with Sigma-Tau Pharmaceuticals, Inc., VP of Operations with AstenJohnson, Inc.. He has a B.A. in Commerce from Concordia University, a graduate diploma in Accountancy from McGill University and a M.B.A. from Duke.